Cutaneous administration of nitroglycerin: a review

Pharmacotherapy
M T Olivari, J N Cohn

Abstract

Chronic administration of nitroglycerin may have important therapeutic effects in patients with angina, acute myocardial infarction, congestive heart failure and peripheral vascular disease. Because of unpredictable oral absorption and short duration of action, topical preparations provide an alternative mode of administration. New controlled release transdermal preparations appear to produce constant plasma nitroglycerin concentrations of 0.2-0.3 ng/ml that persist for up to 24 hours. Additional clinical trials of the therapeutic response to this drug form are necessary, particularly in regard to the relative hemodynamic efficacy and side-effect profile of sustained vs. fluctuating plasma nitroglycerin concentrations.

References

Apr 1, 1977·British Journal of Clinical Pharmacology·H P BlumenthalS K Yap
Dec 1, 1977·Journal of the American Podiatry Association·D R FrancisL E Johnson
May 1, 1978·The American Journal of Cardiology·W D Bussmann, D Schupp
Jan 2, 1975·The New England Journal of Medicine·S E EpsteinD R Redwood
Jan 1, 1975·Circulation·J T FlahertyB Pitt
Apr 1, 1975·British Heart Journal·C E DelgadoD T Kelly
Mar 1, 1975·Circulation·D O WilliamsD T Mason
Aug 1, 1976·The American Journal of Cardiology·J O ParkerP W Armstrong
Aug 1, 1976·The American Journal of Cardiology·N DashkoffB Pitt
Oct 1, 1976·The American Journal of Cardiology·W R TaylorH J Swan
Oct 1, 1976·The American Journal of Cardiology·P W ArmstrongJ O Parker
Oct 1, 1976·British Heart Journal·S G MeisterW S Frankl
Jul 1, 1977·British Heart Journal·K Chatterjee, W W Parmley
Apr 1, 1974·The American Journal of Cardiology·K M KentS E Epstein
Sep 1, 1972·The Journal of Pharmacy and Pharmacology·M G Bogaert, M T Rosseel
Jul 1, 1972·The American Journal of Physiology·R L Schnaar, H V Sparks
May 1, 1968·Circulation Research·W M Fam, M McGregor
Aug 1, 1971·The Journal of Clinical Investigation·L D HorwitzH G Kemp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

Neuropsychiatric Disease and Treatment
M A Martínez-GraneroF Montañes
The American Journal of Geriatric Cardiology
John O Parker
Journal of Human Hypertension
R R RuffoloM A Lukas
© 2021 Meta ULC. All rights reserved